These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 745691)

  • 21. The effect of baclofen and aminooxyacetic acid on the action of drugs stimulating the dopaminergic system.
    Sypniewska M
    Pol J Pharmacol Pharm; 1978; 30(6):755-66. PubMed ID: 573471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of the central effects of d-amphetamine by amantadine. II.
    Prepas S; Menon MK; Clark WG
    Arzneimittelforschung; 1975 May; 25(5):780-2. PubMed ID: 1242323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABA-ergic drugs: effects on conditioning, memory and learning.
    Rayevsky KS; Kharlamov AN
    Pharmacol Res Commun; 1983 Jan; 15(1):85-96. PubMed ID: 6402795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GABA in the ventral tegmental area: differential regional effects on locomotion, aggression and food intake after microinjection of GABA agonists and antagonists.
    Arnt J; Scheel-Krüger J
    Life Sci; 1979 Oct; 25(15):1351-60. PubMed ID: 574606
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological studies on tetrabenazine-induced excited behaviour of rats pretreated with amphetamine or nialamide.
    Scheel-Krüger J; Jonas W
    Arch Int Pharmacodyn Ther; 1973 Nov; 206(1):47-65. PubMed ID: 4798103
    [No Abstract]   [Full Text] [Related]  

  • 27. Potential antidepressive properties of amantadine, memantine and bifemelane.
    Moryl E; Danysz W; Quack G
    Pharmacol Toxicol; 1993 Jun; 72(6):394-7. PubMed ID: 8361950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V; Georgiev V
    Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic studies with 7-benzyl-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid.
    Aceto MD; Harris LS; Lesher GY; Pearl J; Brown TG
    J Pharmacol Exp Ther; 1967 Nov; 158(2):286-93. PubMed ID: 4383638
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological interactions with circling behaviour induced by the piperidinyl indole derivative RU 23686.
    Boissier JR; Oberlander C; Dumont C; Peterfalvi M
    Psychopharmacology (Berl); 1977 Nov; 55(1):53-60. PubMed ID: 23562
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Di-n-propylacetate-induced abstinence behaviour as a possible correlate of increased GABA-ergic activity in the rat.
    de Boer T; Bartels K; Metselaar HJ; Bruinvels J
    Psychopharmacology (Berl); 1980; 71(3):257-67. PubMed ID: 6779333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
    Georgiev VP; Markovska VL; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GABA-mediated behavioral inhibition during ontogeny in the mouse.
    Murphy JM; Meeker RB; Porada KJ; Nagy ZM
    Psychopharmacology (Berl); 1979 Aug; 64(2):237-42. PubMed ID: 115048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the effects of d-amphetamine and morphine upon the locomotor activity of mice treated with drugs which alter brain catecholamine content.
    Villarreal JE; Guzman M; Smith CB
    J Pharmacol Exp Ther; 1973 Oct; 187(1):1-7. PubMed ID: 4746328
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of catecholamines on dexamphetamine-induced changes in locomotor activity.
    Handley SL; Thomas KV
    Psychopharmacology (Berl); 1978 Jul; 58(3):283-8. PubMed ID: 98799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the locomotor activity produced by injection of dibutyryl cyclic 3'5'AMP into the nucleus accumbens of rats.
    Heal DJ; Phillips AG; Green AR
    Neuropharmacology; 1978; 17(4-5):265-70. PubMed ID: 206857
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of DA in the stimulant effect of DITA in mice; comparison with d-amphetamine.
    Abdallah AH; Roby DM; Boeckler WH; Riley CC
    Eur J Pharmacol; 1976 Jan; 35(1):29-34. PubMed ID: 1253826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of diazepam and of agents which change GABAergic functions in immobility in mice.
    Nagatani T; Sugihara T; Kodaira R
    Eur J Pharmacol; 1984 Jan; 97(3-4):271-5. PubMed ID: 6705825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of memantine on various neurobiological processes.
    Osborne NN; Beale R; Golombiowska-Nikitin K; Sontag KH
    Arzneimittelforschung; 1982; 32(10):1246-55. PubMed ID: 6185123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.